P Gines

Summary

Affiliation: University of Barcelona
Country: Spain

Publications

  1. ncbi request reprint Review article: albumin for circulatory support in patients with cirrhosis
    P Gines
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Spain
    Aliment Pharmacol Ther 16:24-31. 2002
  2. ncbi request reprint [Role of albumin in the treatment of hepatorenal syndrome in cirrhosis]
    P Gines
    Unidad de Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Spain
    Gastroenterol Hepatol 28:80-4. 2005
  3. ncbi request reprint Review article: pharmacological treatment of hepatorenal syndrome
    P Gines
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, Instituto Reina Sofia de Investigacion Nefrologica, Barcelona, Spain
    Aliment Pharmacol Ther 20:57-62; discussion 63-4. 2004
  4. ncbi request reprint Management of cirrhosis and ascites
    Pere Gines
    Liver Unit, Hospital Clinic and University of Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain
    N Engl J Med 350:1646-54. 2004
  5. ncbi request reprint Hepatorenal syndrome
    Pere Gines
    Liver Unit, Hospital Cli nic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Lancet 362:1819-27. 2003
  6. ncbi request reprint Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
    J Salo
    Department of Medicine, Hospital Clinic i Provincial, Barcelona, Spain
    J Hepatol 25:916-23. 1996
  7. ncbi request reprint Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
    M Guevara
    Liver Unit, Hospital Clinic i Provincial, University of Barcelona, Catalunya, Spain
    Hepatology 27:35-41. 1998
  8. ncbi request reprint [Vasoconstrictors in the treatment of hepatorenal syndrome]
    R Ortega
    Unitat d Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona
    Nefrologia 22:56-61. 2002
  9. ncbi request reprint A prognostic model for predicting survival in cirrhosis with ascites
    G Fernandez-Esparrach
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, IDIBAPS, Barcelona, Spain
    J Hepatol 34:46-52. 2001
  10. ncbi request reprint Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
    A Gines
    Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    Gastroenterology 111:1002-10. 1996

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Review article: albumin for circulatory support in patients with cirrhosis
    P Gines
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Spain
    Aliment Pharmacol Ther 16:24-31. 2002
    ..By contrast, the administration of albumin without vasoconstrictors has marginal or no effects on renal function in this setting...
  2. ncbi request reprint [Role of albumin in the treatment of hepatorenal syndrome in cirrhosis]
    P Gines
    Unidad de Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona, Spain
    Gastroenterol Hepatol 28:80-4. 2005
  3. ncbi request reprint Review article: pharmacological treatment of hepatorenal syndrome
    P Gines
    Liver Unit, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, Instituto Reina Sofia de Investigacion Nefrologica, Barcelona, Spain
    Aliment Pharmacol Ther 20:57-62; discussion 63-4. 2004
    ..Finally, treatment of patients with HRS with terlipressin before transplantation seems to improve post-transplantation outcome...
  4. ncbi request reprint Management of cirrhosis and ascites
    Pere Gines
    Liver Unit, Hospital Clinic and University of Barcelona, Institut d Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain
    N Engl J Med 350:1646-54. 2004
  5. ncbi request reprint Hepatorenal syndrome
    Pere Gines
    Liver Unit, Hospital Cli nic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain
    Lancet 362:1819-27. 2003
    ..Although these findings need to be confirmed, these two strategies represent innovative approaches to lower the frequency of HRS in clinical practice...
  6. ncbi request reprint Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
    J Salo
    Department of Medicine, Hospital Clinic i Provincial, Barcelona, Spain
    J Hepatol 25:916-23. 1996
    ..The renal effects of the i.v. infusion of norepinephrine plus prostacyclin in patients with hepatorenal syndrome were also assessed...
  7. ncbi request reprint Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
    M Guevara
    Liver Unit, Hospital Clinic i Provincial, University of Barcelona, Catalunya, Spain
    Hepatology 27:35-41. 1998
    ....
  8. ncbi request reprint [Vasoconstrictors in the treatment of hepatorenal syndrome]
    R Ortega
    Unitat d Hepatologia, Institut de Malalties Digestives, Hospital Clinic, Barcelona
    Nefrologia 22:56-61. 2002
  9. ncbi request reprint A prognostic model for predicting survival in cirrhosis with ascites
    G Fernandez-Esparrach
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, IDIBAPS, Barcelona, Spain
    J Hepatol 34:46-52. 2001
    ..The aim of the current study was to develop a prognostic model to estimate survival of patients with cirrhosis and ascites...
  10. ncbi request reprint Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
    A Gines
    Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    Gastroenterology 111:1002-10. 1996
    ..This study investigated the clinical importance of paracentesis-induced-circulatory dysfunction and compared the efficacy of albumin, dextran 70, and polygeline in preventing this complication...
  11. ncbi request reprint [Consensus document on the treatment of ascites, dilutional hyponatremia and hepatorenal syndrome in liver cirrhosis]
    P Gines
    Servei d Hepatologia, Hospital Clinic de Barcelona, Barcelona, Spain
    Gastroenterol Hepatol 27:535-44. 2004
  12. ncbi request reprint Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites
    J Claria
    DNA Unit, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Universitat de Barcelona, Spain
    Gastroenterology 115:147-56. 1998
    ..The aim of this study was to investigate the lipoxygenase pathway of arachidonic acid metabolism and its influence in leukocyte trafficking in patients with cirrhosis and ascites...
  13. ncbi request reprint Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis
    A Cardenas
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, University of Barcelona, Spain
    Hepatology 34:671-6. 2001
    ..Renal failure is a strong predictor of mortality in patients with cirrhosis and gastrointestinal bleeding...
  14. ncbi request reprint Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis
    A Cardenas
    Hospital Clinic, Barcelona and the University of Barcelona School of Medicine, Barcelona, Spain
    Semin Nephrol 21:308-16. 2001
    ..Likewise, the description of predictive factors for the survival of patients with cirrhosis has been of major importance for the identification of patients candidates for liver transplantation...
  15. doi request reprint Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study
    P Gines
    Liver Unit, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, CIBER de Enfermedades Hepáticas y Digestivas CIBEREHD, Barcelona, Catalunya, Spain
    Aliment Pharmacol Ther 31:834-45. 2010
    ..There is little information on the effects of vaptans in patients with cirrhosis...
  16. doi request reprint Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease
    M E Baccaro
    Liver Unit, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Barcelona, Catalunya, Spain
    Nephrol Dial Transplant 25:2356-63. 2010
    ..However, 3-year survival of patients with cirrhosis treated with CLKT is excellent...
  17. ncbi request reprint Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility
    M N Görbig
    Institute of Digestive Diseases, Hospital Clinic, Institut d Investigacions Biomèdiques August Pi Sunyer, University of Barcelona School of Medicine, Catalonia, Spain
    J Hepatol 34:222-9. 2001
    ..It is unknown whether human HSCs have receptors for and are able to synthesize the vasodilator peptide adrenomedullin (ADM), a peptide produced by most contractile cells...